Page last updated: 2024-08-16

ici 204,219 and acrivastine

ici 204,219 has been researched along with acrivastine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Helbling, A; Pichler, C; Pichler, WJ; Reimers, A; Yawalkar, N	1

Trials

1 trial(s) available for ici 204,219 and acrivastine

Article	Year
Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2002, Volume: 32, Issue:12 Topics: Adolescent; Adult; Aged; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Sulfonamides; Tosyl Compounds; Treatment Outcome; Triprolidine; Urticaria	2002

Article

Year

Zafirlukast has no beneficial effects in the treatment of chronic urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2002, Volume: 32, Issue:12

Topics: Adolescent; Adult; Aged; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Sulfonamides; Tosyl Compounds; Treatment Outcome; Triprolidine; Urticaria

2002